MedTrace Logo

Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma

NCT01589198 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2017-03-29

No results posted yet for this study

Summary

The purpose of this study is to learn more about asthma in people who are not well-controlled with current asthma medication (refractory asthma). The investigators will compare data from refractory asthmatic patients here at National Jewish Health to mild asthmatics subjects and to people without asthma. Study experiments involve looking at samples from all 3 groups and comparing them at a molecular level. These laboratory experiments may help identify subtypes of refractory asthmatics that require different treatments.

Conditions

Sponsors & Collaborators

  • MedImmune LLC

    collaborator INDUSTRY

  • National Jewish Health

    lead OTHER

Principal Investigators

  • Richard Martin, MD · National Jewish Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01589198 on ClinicalTrials.gov